Cigna (CI)
NYSEHealth CareHealthcare PlansSnapshot 2026-07-07
$286.60+1.64%
Close 2026-07-07 · 1-day change
Reading CI? This analysis is rebuilt every market day. Get it tracked free. No credit card.
Track CI free→NYSEHealth CareHealthcare PlansSnapshot 2026-07-07
Reading CI? This analysis is rebuilt every market day. Get it tracked free. No credit card.
Track CI free→A long-form read on the 1–3 year hold thesis. Slower and deeper than the daily snapshot — it refreshes only when the evidence moves.
This is a durable compounder investment with a focus on steady growth. The current thesis is supported by strong recent financial performance and a commitment to management priorities, although there are mixed signals regarding achieving income targets.
The market currently prices Cigna as cheap compared to its peers, reflecting a low expectations gap. There is a low level of fragility in the stock's execution quality, suggesting that the current valuation may be justified.
Management is on track to increase adjusted income and reach revenue goals, which supports a positive fundamental trajectory. However, there is a moderate risk of missing earnings estimates, though the probability is relatively low.
The long-term thesis hinges on the performance of sector bellwethers like UNH, CVS, and ELV. If these companies continue to perform well, it could provide a favorable tailwind for Cigna, while any downturn in their performance could pose a risk.
Overall, Cigna's fundamentals and sector context appear solid for the next 1 to 3 years. Not investment advice.
The most important moves since the prior daily snapshot.
Yes, our read has strengthened. The latest earnings beat supports the positive outlook. Cigna's investment in specialty pharmacy also enhances growth in adjusted income from operations. There are no new threats to the thesis.
as of 2026-07-07
Specific, dated things to watch for, each with what would confirm it and what would prove it wrong.
Why it matters: This metric shows if Cigna is on track to meet its 2026 income goals. Strong performance supports growth confidence.
Confirms:Q2 adjusted income from operations was $7.79 or more per share.
Disproves:Q2 adjusted income from operations was below $7.79 per share.
Why it matters: This segment's success is key for overall revenue growth and making money.
Confirms:Evernorth Health Services revenue grows more than 9% year over year.
Disproves:Evernorth Health Services revenue grows less than 9% year over year.
Why it matters: More customer relationships show Cigna's strength in the market. There is a strong demand for services.
Confirms:Total customer relationships rise from 185.5 million in Q1 2026.
Disproves:Total customer relationships fall from 185.5 million in Q1 2026.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.